FDA Adverse Event Injury Summary report: N

JUVEDERM VOLUMA XC/LIDO (VOLUME UNKNOWN)

MDR report key: 9457878 · Received December 12, 2019

Report

Report Number
3005113652-2019-00858
Event Type
Injury
Date Received
December 12, 2019
Date of Event
August 20, 2013
Report Date
December 12, 2019
Manufacturer
ALLERGAN (PRINGY)
Product Code
LMH
PMA / PMN Number
P110033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE REPORTER HAS DECLINED TO PROVIDE ALLERGAN FURTHER INFORMATION REGARDING EVENT, PRODUCT, OR PATIENT DETAILS. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Description of Event or Problem · 1

HEALTHCARE PROFESSIONAL REPORTS 2 ML JUVÉDERM¿ VOLUMA¿ WITH LIDOCAINE INJECTION TO CHEEKS, UPPER NLF AND MARIONETTE. PATIENT EXPERIENCED DELAYED ONSET NODULES TO L MARIONETTE 11 MONTHS LATER. THE FOLLOWING MONTH, SYMPTOM APPEARED AT R NLF AND R CHEEK. HA 75 U/ML X 0.3ML TO R CHEEK/NLF PROVIDED AS TREATMENT ONE MONTH LATER. SWELLING CONTINUED. 5 DAYS AFTER TREATMENT, EVENT MUCH IMPROVED. ONE WEEK LATER, ILK 13MG/ML X 0.5ML APPLIED INTO 3 SITES. EVENT RESOLVED THE FOLLOWING MONTH. POTENTIAL TRIGGER NOTED AS GUM IRRITATION WITH INVISALIGN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1253983 JUVEDERM VOLUMA XC/LIDO (VOLUME UNKNOWN) IMPLANT, DERMAL, FOR AESTHETIC USE LMH ALLERGAN (PRINGY) NI

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention